IRIS
LAURIA, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.595
NA - Nord America 1.201
AS - Asia 634
SA - Sud America 83
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.165
RU - Federazione Russa 660
IT - Italia 436
SG - Singapore 307
CN - Cina 160
DE - Germania 138
HK - Hong Kong 104
NL - Olanda 91
BR - Brasile 78
FI - Finlandia 74
UA - Ucraina 66
FR - Francia 54
CA - Canada 30
IE - Irlanda 26
VN - Vietnam 26
IN - India 24
GB - Regno Unito 20
CI - Costa d'Avorio 13
SE - Svezia 8
ZA - Sudafrica 8
AT - Austria 6
ES - Italia 3
KR - Corea 3
MX - Messico 3
AR - Argentina 2
DO - Repubblica Dominicana 2
EU - Europa 2
IL - Israele 2
IQ - Iraq 2
LT - Lituania 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BE - Belgio 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
IR - Iran 1
LK - Sri Lanka 1
MK - Macedonia 1
PY - Paraguay 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.538
Salva come PNG Salva come JPEG
Città #
Chandler 242
Singapore 190
Moscow 174
Hong Kong 104
Amsterdam 87
Napoli 86
Santa Clara 63
Ashburn 60
Millbury 59
Jacksonville 47
Beijing 41
Princeton 40
Nanjing 34
Naples 31
Munich 26
Dong Ket 24
Helsinki 22
Turku 21
Wilmington 20
Des Moines 19
Pune 16
Toronto 12
Boston 11
Milan 11
Ottawa 11
Tianjin 11
Seattle 10
Lawrence 9
Falkenstein 8
Falls Church 8
Nanchang 8
Shenyang 8
Frankfurt am Main 7
Jiaxing 7
New York 7
Nuremberg 7
Redwood City 7
Rome 7
Rozzano 7
Ann Arbor 6
Casoria 6
São Paulo 6
Belo Horizonte 5
Dallas 5
Leawood 5
London 5
Los Angeles 5
Salerno 5
Bologna 4
Changsha 4
Dearborn 4
Dublin 4
Fairfield 4
Menfi 4
San Mateo 4
Taizhou 4
The Dalles 4
Washington 4
Augusta 3
Battipaglia 3
Brooklyn 3
Charlotte 3
Duncan 3
Florence 3
Hangzhou 3
Hebei 3
Jinan 3
Mexico City 3
Montreal 3
Ningbo 3
Pomigliano d'Arco 3
Rio de Janeiro 3
Serravalle Scrivia 3
Shanghai 3
Vila Velha 3
Villaricca 3
Blumenau 2
Boardman 2
Caivano 2
Cape Town 2
Caserta 2
Castellammare Di Stabia 2
Catania 2
Cernusco sul Naviglio 2
Chicago 2
Cuiabá 2
Curitiba 2
Erbil 2
Guangzhou 2
Hanoi 2
Johannesburg 2
Kunming 2
Latina 2
Mariano Comense 2
Montauro 2
Mugnano Di Napoli 2
Mumbai 2
Nola 2
Norwalk 2
Novo Hamburgo 2
Totale 1.752
Salva come PNG Salva come JPEG
Nome #
null 223
Manuale di Oncologia Clinica 135
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 114
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 114
Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine 107
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. 91
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. 90
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 81
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature 80
Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study 76
Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour 76
Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis 74
Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma 74
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study 74
Chlorambucil, Vincristine and Cytarabine (COA) treatment of low grade lymphomas 73
Tumor characteristics and prognosis in familial breast cancer 73
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues 73
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 70
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. 68
null 67
Core curriculum. Oncologia clinica 66
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 66
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. 65
Changing presentation in non Hodgkin lymphoma". 65
Advanced and Locally unresectable gastric carcinoma: five years of survival with good quality of life. 65
Partial deficiency of adrenal 11-hydroxylase: A possible cause of primary hypertension 65
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 65
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials 64
Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer 64
CAVBP-DEP Altemative Chemotherapy for the treatment of intermediate and high grade non Hodgkin lymphoma: final results of a pilot study. 63
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. 63
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 62
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer. 61
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study 60
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 58
Bone involvement by adenocarcinoma of the uterine cervix: a rare entity 58
Core curriculum. Oncologia clinica 58
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. 57
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. 55
Capitolo 15: i Tumori Ginecologici 55
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy. 54
Comparison of Tropisetron (ICS 205-930) with alizapride plus dexamethasone in the prevention of emesis induced by repeated cisplatin administration. 53
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 53
Tailored therapy for aggressive non-Hodgkin’s lymphoma: results of a phase II study with a long-term follow-up. 52
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 52
Maintenance therapy with recombinant Interferon Alpha-2b (IFN) in prognostically in prognastically unfavourable aggressive non-Hodgkin’s lymphomas. 50
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 49
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial. 49
'Primary Bone Lymphoma". 47
Salvage chemotherapy for non Hodgldn's lymphoma of unfavorable histology with a combination of CCNU and Vinblastine. 40
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety 31
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. 29
Totale 3.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 0 0 0 0 0 0 0 40
2020/2021267 8 12 31 29 29 26 26 8 34 3 32 29
2021/2022342 8 1 7 5 3 13 6 9 26 40 111 113
2022/2023523 57 65 18 42 57 54 3 39 74 92 16 6
2023/2024284 11 52 32 22 17 47 5 29 4 5 48 12
2024/20251.531 63 42 13 20 66 80 137 117 89 152 669 83
Totale 3.627